Name | Number of supported studies | Average coverage | |
---|---|---|---|
B cell | 31 studies | 34% ± 11% | |
plasmacytoid dendritic cell | 21 studies | 62% ± 18% | |
memory B cell | 18 studies | 34% ± 8% | |
naive B cell | 16 studies | 29% ± 11% | |
immature B cell | 6 studies | 49% ± 8% | |
precursor B cell | 5 studies | 50% ± 11% | |
brush cell | 4 studies | 66% ± 17% | |
dendritic cell | 3 studies | 31% ± 8% | |
germinal center B cell | 3 studies | 46% ± 5% | |
plasma cell | 3 studies | 36% ± 15% |
Insufficient scRNA-seq data for expression of SPIB at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
pancreas | 74% | 115.19 | 244 / 328 | 77% | 8.12 | 137 / 178 |
lung | 57% | 50.34 | 327 / 578 | 59% | 6.90 | 680 / 1155 |
intestine | 67% | 1488.79 | 651 / 966 | 42% | 4.88 | 222 / 527 |
prostate | 52% | 95.51 | 128 / 245 | 49% | 1.93 | 248 / 502 |
lymph node | 0% | 0 | 0 / 0 | 100% | 184.64 | 29 / 29 |
spleen | 100% | 2306.13 | 241 / 241 | 0% | 0 | 0 / 0 |
peripheral blood | 97% | 2106.48 | 904 / 929 | 0% | 0 | 0 / 0 |
stomach | 28% | 27.70 | 102 / 359 | 47% | 7.98 | 133 / 286 |
tonsil | 0% | 0 | 0 / 0 | 69% | 39.53 | 31 / 45 |
bladder | 24% | 32.81 | 5 / 21 | 31% | 4.16 | 154 / 504 |
breast | 17% | 14.44 | 78 / 459 | 37% | 4.56 | 410 / 1118 |
esophagus | 22% | 22.59 | 315 / 1445 | 30% | 2.05 | 55 / 183 |
thymus | 23% | 74.99 | 147 / 653 | 26% | 3.40 | 158 / 605 |
kidney | 34% | 49.06 | 30 / 89 | 12% | 0.36 | 109 / 901 |
skin | 3% | 1.44 | 51 / 1809 | 40% | 2.89 | 187 / 472 |
muscle | 36% | 25.22 | 293 / 803 | 0% | 0 | 0 / 0 |
uterus | 2% | 0.77 | 3 / 170 | 32% | 5.64 | 148 / 459 |
liver | 8% | 4.21 | 18 / 226 | 17% | 3.24 | 71 / 406 |
ovary | 6% | 3.73 | 11 / 180 | 13% | 0.27 | 58 / 430 |
adipose | 15% | 11.84 | 176 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 12% | 16.51 | 165 / 1335 | 0% | 0 | 0 / 0 |
brain | 5% | 3.54 | 127 / 2642 | 2% | 0.81 | 14 / 705 |
eye | 0% | 0 | 0 / 0 | 5% | 0.18 | 4 / 80 |
heart | 4% | 2.73 | 31 / 861 | 0% | 0 | 0 / 0 |
adrenal gland | 1% | 0.27 | 2 / 258 | 1% | 0.02 | 3 / 230 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0030154 | Biological process | cell differentiation |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0000785 | Cellular component | chromatin |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_1990837 | Molecular function | sequence-specific double-stranded DNA binding |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0001228 | Molecular function | DNA-binding transcription activator activity, RNA polymerase II-specific |
GO_0005515 | Molecular function | protein binding |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
Gene name | SPIB |
Protein name | Transcription factor Spi-B Spi-B transcription factor |
Synonyms | |
Description | FUNCTION: Sequence specific transcriptional activator which binds to the PU-box, a purine-rich DNA sequence (5'-GAGGAA-3') that can act as a lymphoid-specific enhancer. Promotes development of plasmacytoid dendritic cells (pDCs), also known as type 2 DC precursors (pre-DC2) or natural interferon (IFN)-producing cells. These cells have the capacity to produce large amounts of interferon and block viral replication. May be required for B-cell receptor (BCR) signaling, which is necessary for normal B-cell development and antigenic stimulation. . |
Accessions | ENST00000439922.6 [Q01892-3] ENST00000594685.1 ENST00000595883.6 [Q01892-1] ENST00000596074.5 ENST00000270632.7 [Q01892-2] Q01892 M0R037 M0R2J9 ENST00000597855.5 M0QXA8 |